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January 12th, 2016
To: The editorial board, Journal of Affective Disorders
Please find attached a manuscript entitled “Risk of incident cardiovascular events amongst
individuals with anxiety and depression: A prospective cohort study in the east London 
primary care database” for your consideration. The paper details are large observational 
study undertaken in a primary care database covering the entire population of east 
London, examining the relationship between the two common psychiatric disorders of 
anxiety and depression and risk of two major cardiovascular outcomes, myocardial 
infarction and stroke.
The study demonstrates an increased risk of CVD in both populations, particularly amongst
patients with depression, and highlights the importance of antidepressant prescribing and 
control of traditional cardiovascular risk factors. This paper contributes to a better 
understanding of the association between anxiety and CVD, which has received little 
attention to date.
We hope this topic is of interest to the readership of the Journal of Affective Disorders
Sincerely,
Dr. Rohini Mathur (corresponding author)
Clinical Effectiveness Group
Centre for Primary Care & Public Health
Yvonne Carter Building 
58 Turner Street
London, E1 2AB
r.mathur@qmul.ac.uk
Thank you for reviewing our manuscript. We have modified it according to your suggestions 
and we think that as a result of that it is now a very improved piece of research.
1) Diagnostic Read codes: Although according to the authors' response one of them is a 
consultant psychiatrist, who reviewed the lists of read codes to decide which ones should and 
should not be included, the nature of these codes, which do not correspond to ICD codes, 
remains unclear. How do the clinicians decide according to this code whether a depression or 
an anxiety disorder is present? Is there a list of symptoms or is there a prototypical 
description of the mood or anxiety syndrome provided to the clinicians? 
In UK primary care, depression and anxiety are coded using a combination of codes for symptoms 
and diagnoses.
A recent UK database study has shown that the use of diagnostic codes has decreased while the use 
of symptom codes has increased, likely due to the fact that GPs may code the progression of the 
disorder in a longitudinal manner, and may be increasingly reticent to over medicalize patients. (1)
A systematic review of the validity of diagnoses in the General Practice Research Database, which 
collects data identical to that used in our study has shown that 83% of cases with mental and 
behavioural disorders present in the GPRD were confirmed by general practitioners.(Herrett et al. 
2010)
Particularly for the heterogeneous category of anxiety disorders including Generalized 
Anxiety Disorder, Panic Disorder, Agoraphobia, Social Phobia and Specific Phobia according 
to the DSM and ICD system it would be crucial to know which of these disorders were 
considered within the anxiety Read code. 
All of the Read codes used for Anxiety and Depression in this study are listed in the appendix.
Moreover, the authors did not provide data on the reliability of the diagnostic assignment by 
GPs using Read codes for depression and anxiety disorders and finally, I could not find a 
limitation statement acknowledging the absence of operationalized diagnostic criteria and the 
lack of reliability data.
Clinical data on anxiety and depression are being widely used for research purposes since large 
electronic databases have become available. Electronic health databases provide a platform to 
conduct high resolution research on very specific and clinically meaningful outcomes that are difficult
to investigate with smaller cohorts.(2,3)
The quality of data for mental health in primary care records has been demonstrated to be high 
enough for epidemiological research. However, we, do also acknowledge the limitations of these 
data. For example, the over diagnosis of depression, coupled with the under diagnosis of those who 
have depression but due to reduced motivation, don't seek medical help, may lead to an 
underestimation of the associations between depressive disorders and CVD.(4)
The capture and coding of both anxiety and depressive disorders is clearly outlined in the UK National
Institute for Health and Care Excellence guidelines, and thus we expect that general practitioners will 
code this information consistently and to a high level.(5,6) Furthermore, incentive payments for the 
accurate recording of depression as part of the Quality and Outcomes Framework were introduced in
2006.
To improve this paper, we have commented on limitations of the data. Specifically that:
1. Coding of diagnoses is opportunistic and requires the patient to attend primary care and 
consult with their GP.
2. The potential over diagnosis of depression, combined with the under-diagnosis of those who 
have depression but due to reduced motivation, don't seek medical help, may lead to an 
underestimation of the associations between depression and CVD.
Subsequent to the submission of this paper, a research paper validating the capture of common 
mental disorders in routine electronic health databases has developed an algorithm using that GP 
coded anxiety and depression diagnoses and symptoms which yields both high sensitivity and 
specificity. We will explore using this algorithm for future research into common mental disorders 
using routine electronic health databases.
2) Comorbidity between depression and anxiety: According to the authors' response analyses 
could not be conducted using models that simultaneously included depression and anxiety 
given that clinicians generally only assigned one or the other diagnosis but not the two 
together. This is a serious problem given the high comorbidity between depression and 
anxiety disorders. Indeed, in a large study conducted in primary care Sartorius et al. could 
show that more than 80% of subjects with anxiety disorders also met criteria for depression 
(Sartorius N, Ustün TB, Lecrubier Y, Wittchen HU. Depression comorbid with anxiety: 
results from the WHO study on psychological disorders in primary health care. Br J 
Psychiatry Suppl. 1996 Jun;(30):38-43). Accordingly, the interpretation of results of the effect
of anxiety disorders without adjusting for the effect of depression remains problematic. 
However, this issue cannot be changed according to the authors' response.
Examining co-morbidity between anxiety and depression was one of our original aims. However, in 
our study population, only 5,132 individuals from our study sample of 525,000 patients had both 
conditions. Within this population there were only 18 incident stroke events and 54 incident MI 
events, and thus our study was under-powered to adequately examine a primary association 
between co-morbid anxiety/depression and our CVD outcomes of interest.
However, we are grateful for your suggestion of including depression/anxiety and additional 
predictor variables in our existing analysis models. We have now included the results of this 
additional analysis in a third analysis model (“Model 3”) - the results of which are shown in the 
updated tables 2 and 3 and discussed in the Results section of the paper.
There are still some less serious limitations:
1) According to the authors' response physical activity could only be measured in 27.6% of 
the sample and therefore adjustment was not possible for this variable. This should be stated 
in the limitation paragraph.
We have stated this as a limitation in the discussion.
2) Subjects with missing information on hyperlipidemia and tobacco consumption considered
as having non-raised cholesterol levels and as noncurrent smokers, respectively: The non-
systematic assessment of these variables should also be mentioned in the limitation 
paragraph.
We have stated this as a limitation in the discussion.
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Abstract 
Background: It is unknown how risk of myocardial infarction and stroke differ 
for patients with and without anxiety or depression, and whether this risk can be 
explained by demographics, medication use, cardiovascular risk factors. The aim 
of this study is to quantify differences in risk of non-fatal MI or stroke among 
patients with anxiety or depression. 
Methods: Prospective cohort study examining risk of incident MI and stroke 
between March 2005 and March 2015 for 524,952 patients aged 30 and over 
from the east London primary care database for patients with anxiety or 
depression.
Results:  Amongst 21,811 individuals with depression at baseline, 1.2% had MI 
and 0.4% had stroke. Of 22,128 individuals with anxiety at baseline, 1.1% had MI
and 0.3% had stroke. Depression was independently associated with both MI and
stroke, whereas anxiety was associated with MI only before adjustment for 
cardiovascular risk factors. Antidepressant use increased risk for MI but not 
stroke. Mean age at first MI was lower in those with anxiety, while mean age at 
first stroke was lower in those with depression.
Limitations: The study was limited to patients currently registered in the 
database and thus we did not have any patients that died during the course of 
follow-up. Conclusions: Patients with depression have increased risk of 
cardiovascular events. The finding of no increased cardiovascular risk in those 
with anxiety after adjusting for cardiovascular risk factors is of clinical 
importance and highlights that the adequate control of traditional risk factors is 
the cornerstone of cardiovascular disease prevention. Targeting management of 
classical cardiovascular risk factors and evaluating the risks of antidepressant 
prescribing should be prioritized.
Keywords: Depression; anxiety; cardiovascular disease; cohort study; primary 
care
Introduction 
The 2010 Global Burden of Disease has identified anxiety and depression as the 
most prevalent mental health conditions worldwide, contributing significantly to 
overall global disease burden and years lived with disability.(Ferrari et al., 2013; 
World Federation For Mental Health, 2012) In the UK, anxiety and depressive 
disorders affect approximately 15% of the adult population.(LSE and The Centre 
for Economic Performance, 2012)
Patients with psychiatric conditions have an increased risk of cardiovascular 
disease (CVD), including myocardial infarction (MI) and stroke.(De Schutter et al.,
2011; Elderon and Whooley, 2013; Hare et al., 2014; Osborn et al., 2007; Tully et 
al., 2015) Both anxiety and depression are common mental disorders, with high 
prevalence in the general population. While the relationship between severe 
mental illness and cardiovascular disease has been widely explored, there is a 
paucity of evidence around the relationship between anxiety and incident 
cardiovascular events.(Bowen et al., 2000; Chou et al., 2012; Davies and 
Allgulander, 2013; Lambiase et al., 2014; Osborn et al., 2007) The burden of CVD
and CVD risk factors is increasing rapidly amongst young, working-age adults.
(Lavie and Milani, 2006; Moran et al., 2014; Poisson et al., 2014) Since 
cardiovascular disease is the leading cause of loss of in disability adjusted life-
years (DALYs) worldwide, this represents the greatest loss for families and 
national economies. Accordingly, it is important to know whether individuals with
anxiety or depressive disorders are at risk of earlier onset of MI and stroke 
compared to individuals without these conditions.(Murray et al., 2012) 
This study aims firstly to quantify the excess risk of non-fatal stroke or MI 
Abbreviations:
MI Myocardial Infarction
CVD Cardiovascular Disease 
EMIS Egton Medical Information Systems    
UK United Kingdom
NHS National Health Service                
2associated with diagnosed anxiety and depressive disorders and antidepressant 
use in an unselected primary care population, and secondly, to test the 
hypothesis that cardiovascular (CV) events may have an earlier presentation in 
patients with anxiety and depressive disorders compared to those without.  We 
hypothesize that risk will be increased in patients with these psychiatric 
conditions compared to those without and that the increased risk can be further 
explained by sociodemographic and cardiovascular risk factors. This work will 
help to identify groups at higher risk for cardiovascular outcomes and potential 
areas for focusing preventive interventions. 
Methods
A prospective cohort study using patients contributing to the east London 
primary care database held by the Clinical Effectiveness Group at Queen Mary, 
University of London was undertaken. The database comprises the electronic 
health records of approximately 950,000 individuals registered with 141 general 
practices across the east London boroughs of Tower Hamlets, Newham, and City 
& Hackney, all of which use EMIS web as their clinical computer system. The 
population of east London is one of the most deprived in the UK and has high 
levels of ethnic diversity, with over 50% of the resident population of non-white 
ethnicity.(Hull et al., 2014; Tower Hamlets Council, 2013) 
The study sample included all adult patients aged 30 and over in March 2015 
who were free from MI or stroke at the start of the study period in March 2005. 
Anonymised demographic, clinical and prescribing data were extracted for all 
individuals meeting the study entry criteria. 
3Read codes are the standard clinical terminology system used in general practice
across the UK.(Chisholm, 1990) Diagnostic Read codes for anxiety and 
depressive disorders were selected by the authors, who comprised general 
practitioners, clinical psychiatrists, and epidemiologists. Diagnoses of diabetes 
mellitus, before March 2005, and MI and stroke, between March 2005 and March 
2015, were defined according the quality and outcomes framework Read code 
specifications.(NHS Employers, 2014) Individuals without a diagnostic Read code 
for each condition were considered to be free from the disease of interest.
Self-reported ethnicity was recorded at the practice during registration or routine 
consultation. Ethnic categories were based on the UK census and for this study 
were condensed into four categories: White (British, Irish, other white), Black 
(Black African, Black Caribbean, other Black) South Asian (Bangladeshi, Pakistani,
Indian, other South Asian) and any other ethnic group. Patients with mixed 
ethnicity were grouped with their parent ethnic minority. Individuals with missing 
ethnicity information were grouped into an “unknown” category (results not 
shown). Deprivation was classified using the Townsend deprivation score, a 
census-based index of material deprivation calculated by the combination of four
variables from the 2001 census: car ownership, overcrowded households, 
households not owner occupied, and unemployment.(Townsend, 1987) 
Systolic and diastolic blood pressure, total cholesterol level, tobacco 
consumption and antidepressant use closest to and before March 2005 were 
extracted to identify baseline values at study entry. Hypertension was identified 
using the clinical Read code for hypertensive disease. Obesity was defined as 
having a body mass index of 30 kg/m2 or above; Hyperlipidemia was defined as 
4having a total cholesterol value of greater than 5 mmol/L; Tobacco consumption 
was dichotomized into current smoker vs. not current smoker.  Individuals 
without Read codes for tobacco consumption were considered to be non-current 
smokers.
Individuals entered the study in March 2005 and were followed up until they 
experienced an incident non-fatal event of MI or stroke during the ten years of 
follow-up. Follow-up time was censored at the end of the study period in March 
2015 if they did not experience the outcome of interest. 
Cox proportional-hazards regression analyses were used to firstly compare the 
risk of incident MI and stroke in patients with and without depression at baseline 
and secondly to compare the risk of incident MI and stroke in patient with and 
without anxiety at baseline. Three regression models were built; The first 
adjusted for age, gender, and ethnic group, the second additionally adjusted for 
diabetes, hypertension, hyperlipidemia, and smoking antidepressant prescribing 
at baseline, obesity, and Townsend deprivation score, and the third additionally 
adjusted for the presence of co-morbid anxiety or depression. Linear regression 
models adjusting for gender and ethnicity were used to compare the age at the 
time of MI and stroke of patients with and without anxiety and depression.  All 
models accounted for clustering of patients within general practices using a 
shared frailty term for practice, which reflects the non-independence of patients 
attending the same health care provider.(Allison, 2014)
5Results  
A total of 524,952 adults aged 30 and over registered with the east London 
primary care database in March 2015 were identified. The characteristics of the 
study sample are presented in table 1. From the total population, 21,811 
individuals had an existing diagnosis of depression at baseline (4.1%) while 
22,128 had an existing diagnosis of anxiety (4.2%). Compared to individuals free 
from psychiatric disorders, individuals with depression or anxiety were older, had
a higher proportion of females and a smaller proportion of individuals from ethnic
minority groups (p<0.001). Prevalence of all clinical co-morbidities at baseline 
was higher in those with anxiety or depressive disorders, most notably 
hyperlipidemia was present in 60% of those with anxiety or depressive disorders 
and 40% of those without anxiety or depressive disorders (p<0.001). Similarly, 
40% of those with anxiety or depressive disorders were identified as current 
smokers, compared to 27% of the general population. Incidence of both MI and 
stroke was doubled for those with anxiety or depressive disorders compared to 
those without (p<0.001).
(Insert table 1 here)
As all included patients were necessarily registered in the database in March 
2015, all were able to contribute a full ten years of follow-up time to the study. 
Cumulative-hazard curves illustrating the increased cumulative incidence of MI 
and Stroke in individuals with anxiety or depression compared to those without 
are shown in figure 1.
(Insert figure 1 here)
6Cox proportional hazards models for the risk of incident non-fatal MI and stroke 
for patients with and without anxiety are presented in table 2. After adjusting for 
age, gender, and ethnic group (model 1), the risk of MI was raised by 33% in 
those with anxiety relative to those without (HR 1.33, CI95% 1.17, 1.52). After 
adjustment for baseline risk factors and deprivation in model 2, the association 
between anxiety and MI was attenuated, and association did not reach the level 
of statistical significance (HR 1.10, CI95% 0.96, 1.26).  This lack of association 
remained after, adjustment for co-morbid depression in model 3 (HR 1.08, CI95%
0.94, 1.24). An independent association between antidepressants and MI was 
observed in the analysis for anxiety (HR 1.25, CI95% 1.13, 1.39). No evidence for
a relationship between anxiety and stroke was evident in any of the survival 
analysis models (Table 2). 
(Insert table 2 here)
Cox proportional hazards models for the risk of incident non-fatal MI and stroke 
for patients with and without depressive disorders are presented in table 3. After 
adjusting for age, gender, and ethnic group in model 1, the risk of MI was raised 
by 52% in those with depressive disorders compared to those without (HR 1.52 
CI95% 1.34, 1.73). The risk of stroke was raised by 43% in those with depressive 
disorders compared to those without after adjusting for the same (HR 1.43 CI95%
1.11, 1.78). The independent effect of depressive disorders on risk of incident MI 
and stroke remained after additionally adjusting for cardiovascular risk factors, 
medication use, and deprivation in model 2 (MI HR 1.22, CI95% 1.06, 1.40, 
Stroke HR 1.29, CI95% 1.00-1.67). Finally, adjusting for the presence of anxiety 
at baseline in model 3 did not have an appreciable effect on the independent 
effect of depressive disorders on MI and stroke. As with the previous analysis, 
independent associations between antidepressants and MI were also observed in
7the analysis for depression.
(Insert table 3 here)
Multivariable analyses examining differences in age at first CVD presentation 
according to psychiatric condition showed that anxiety was associated with an 
earlier presentation of MI 3.6 years (2.1-5.0) p<0.001 and depression was 
associated with an earlier presentation of strokes 4.1 years (1.1-7.1) p=0.008. 
There were no significant associations between depression and age at time of MI,
or anxiety and age at the time of stroke (Table 4). 
(Insert table 4 here)
8Discussion 
Principal Findings
This study has used a large electronic health database to highlight the 
heterogeneity of risk of cardiovascular outcomes according to psychiatric 
disorder in an ethnically and socially diverse population. While the study 
demonstrates a strong relationship between depression and cardiovascular 
disease, the evidence for a relationship between cardiovascular disease and 
anxiety is weaker. The study shows that the mean age at first MI is lower in those
with anxiety, while mean age at first stroke is lower in those with depression. 
Furthermore, the study has shown a strong independent effect of antidepressant 
on risk of MI, but not stroke. Our findings show that traditional cardiovascular risk
factors can explain part of the association between anxiety, depression and 
cardiovascular disease. This is encouraging as the majority of these modifiable 
risk factors can be managed in primary care. The association between anxiety 
and incident MI was reduced after adjustment for cardiovascular risk factors. 
Traditional cardiovascular risk factors and antidepressant use accounted for a 
greater amount of the association between depression and MI, as evidenced by 
the risk associated with depressive disorders decreasing from 52% to 21% after 
full adjustment, and a smaller proportion of the association between depression 
and stroke (reduction in risk associated with depressive disorders from 40% to 
29%). 
Comparisons with existing literature
The associations between depressive disorders/anxiety and MI, and between 
depressive disorders and stroke confirm those of previous studies.(Dong et al., 
92012; Pan et al., 2014; Roest et al., 2010; Van der Kooy et al., 2007) While strong
evidence for a relationship between anxiety and fatal myocardial has been 
found, the evidence for a relationship with non-fatal MI is more equivocal.(Roest 
et al., 2010). Anxiety has been shown to increase risk of incident stroke in recent 
studies in a US setting.(Lambiase et al., 2014; Thurston et al., 2013) The lack of 
a relationship in our study may be due to lack of reliable assessment of anxiety, 
or the fact that we did not capture fatal events, and may have thus 
underestimated the relationship between anxiety and incident CVD.
The finding of increased cardiovascular risk amongst people with diagnosed 
depression reinforces that of recent studies: A 2014 meta-analysis of 28 cohort 
studies (n= 681,139) examining the risk of incident stroke in patients with 
depression reported a pooled estimate of 1.40 (CI95% 1.27-1.53) which aligns 
closely with the findings reported in above.(Barlinn and Kepplinger, 2015) Of the 
28 studies, two were based in the UK; the first reported no relationship between 
stroke and depression or anxiety, while the second reported a relationship 
between depression and coronary heart disease, but not stroke. (Surtees et al., 
2008)(Brunner et al., 2014)
Associations with antidepressant prescribing
The independent association between antidepressants and cardiovascular 
outcomes has been demonstrated before.(Pan et al., 2014) Clinical prescribing in
general practice is largely guided by evidence from randomized control trials, 
which tend to be conducted in idealized populations and have a short duration. 
In the absence of RCTs, the long term observation and follow-up of patients via 
routine electronic health databases will provide the timeliest evidence around 
10
the benefits and risks of medication use in the general population.(Ayerbe et al., 
2014; Coupland et al., 2011) While we cannot infer causality from our 
observations, our results add to a significant body of evidence suggesting that 
antidepressants should be prescribed, balancing the benefits with the negative 
side effects associated with them in the long term. 
Strengths
Clinical data on anxiety and depression have been widely used for research 
purposes since large electronic databases have become available. Electronic 
health databases provide a platform to conduct high resolution research on very 
specific and clinically meaningful outcomes that are difficult to investigate with 
smaller cohorts. (Daskalopolou et al., 2016; Chou et al., 2012).The east London 
database covers a large, unselected, and geographically contiguous population, 
allowing for the capture of sufficient numbers of patients with the two most 
common psychiatric conditions to explore the relationship with cardiovascular 
outcomes. Given that 99% of the UK population is registered with a general 
practitioner, we are likely to have captured an accurate cross-section of the 
population of east London. The findings of this study can be generalized to other 
primary care populations in urban settings with high ethnic and social diversity.
The east London database captures all prescriptions issued by the general 
practice team. Though the database does not provide information on whether 
the prescriptions are filled, a comparison of prescribing data from electronic 
health databases and NHS dispensing data shows the two sources to be highly 
comparable, with 97% of cardiovascular medications dispensed as prescribed.
(The NHS Information Centre, 2011)
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The prospective nature of this study ensured that we captured incident 
cardiovascular events recorded after the onset of depression or anxiety, limiting 
the possibility of reverse causality. All data were entered into the medical record 
prospectively, minimizing the risk of recall bias or inaccurate self-report. The 
study accounted for the presence of well-established risk factors for 
cardiovascular disease and benefitted from high levels of ethnicity recording and 
patient level deprivation data, which allowed for a more accurate estimation of 
the independent effect of anxiety and depressive disorders on the CVD 
outcomes. This study has demonstrated that it is possible to replicate and 
confirm results from non-observational studies and trials in an electronic health 
database setting using observational epidemiology methodology. 
The capture and coding of both anxiety and depressive disorders is clearly 
outlined in the UK National Institute for Health and Care Excellence guidelines, 
and thus we expect that general practitioners will code this information 
consistently and to a high level. (NICE, 2014; NICE, 2011) Furthermore, incentive 
payments for the accurate recording of depression as part of the Quality and 
Outcomes Framework were introduced in 2006. A systematic review of the 
validity of diagnoses in the General Practice Research Database, which collects 
data identical to that used in our study has shown that 83% of cases with mental
and behavioural disorders present in the GPRD were confirmed by general 
practitioners. (Herrett et al., 2010)
Limitations
Anxiety and depressive disorders tend to be under-diagnosed in primary care 
settings. (Rait et al., 2009; Robert et al., 1997; Stein and Sareen, 2015) 
Furthermore, lower rates of healthcare usage amongst patients with these 
12
conditions may limit the opportunity to recognize major cardiovascular 
conditions in these populations.(Yeomans et al., 2014). 
The over diagnosis of depressive disorders, coupled with the under diagnosis of 
those who have depressive disorders but don't seek medical help due to reduced
motivation, may lead to an underestimation of the associations between 
depressive disorders and cardiovascular disease. (Mitchell et al., 2009) As a 
result, this study may have had reduced power to detect the true relationship 
between anxiety and depressive disorders and subsequent cardiovascular 
events. Furthermore, due to the nature of the data, we were unable to assess 
disease stage (for example, current, remitted, mild, moderate, severe), which 
could have an impact on the risk of incident cardiovascular disease. Data on 
physical activity were only available for 27.6% of the study sample and therefore
adjustment for this confounder was not possible.
The study included all patients currently registered in the database in 2015 and 
thus we did not have any patients that died during the course of follow-up. Lack 
of linkage to hospital episode statistics or mortality data meant that we were 
unable to examine all-cause mortality or CV related mortality in the study 
population.  Furthermore we were unable to determine whether any hospital 
admissions for MI or stroke had occurred prior to study entry, and thus we had to
assume that the first recorded event in the primary care database was truly 
incident. 
Though our study accounted for ever use of antidepressants, it did not take 
consider the dosage, drug type, or continuity of prescribing. The study also did 
not consider antipsychotic medication which has been shown to increase risk of 
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stroke, but not MI. (Brauer et al., 2011; Douglas and Smeeth, 2008)
We examined incidence of cardiovascular outcomes over the previous 10 years; 
this was due to confidence in the quality of the recorded covariate and diagnostic
data following the introduction of the Quality and Outcomes Framework in 2004, 
which rewarded general practices for high quality and complete recording of 
priority clinical conditions and risk factors across the UK.(NHS Employers, 2014)
We were unable to examine a “disease-free” cohort and follow them up 
prospectively to compare CVD outcomes between patients who developed 
anxiety/depression and those who did not. Furthermore, our use of baseline 
measures of key cardiovascular risk factors did not fully account for the time 
varying nature of risk factor control, which can change in response to both 
pharmacological and non-pharmacological intervention by the clinician, and in 
response to changes in morbidity status of the patient.
Unanswered questions and future research
Coded diagnoses for anxiety and depressive disorders do not provide any 
information as to the severity of the condition, which is likely to affect 
subsequent healthcare usage and cardiovascular risk. Using additional 
information to refine the classification of disease severity would improve the 
estimation of the independent effect of anxiety and depressive disorders on 
subsequent cardiovascular outcomes.(Kubzansky et al., 1998)
Small numbers of patients with diagnosed psychiatric conditions other than 
14
anxiety and depressive disorders meant that we were unable to extend the same
analysis to other relevant conditions such as those with schizophrenia, bipolar 
disorder, or personality disorders, which have been found to have a significant 
relationship with cardiovascular outcomes.(Ringen et al., 2014)  For the same 
reason, we were unable to estimate CV risk in individuals with more than one 
prevalent psychiatric condition at baseline. Conducting the analysis in larger or 
multiple electronic health databases would allow for the study of a wider range 
of psychiatric disorders would be valuable in confirming or refuting the findings, 
and also exploring risk in patients with concurrent anxiety and depressive 
disorders.
Clinical Relevance 
In conclusion, the evidence provided in this paper contributes to a better 
understanding of the association between anxiety and CVD, which has received 
little attention and confirms existing literature around the relationship between 
depression and MI/stroke. The weaker relationship between anxiety and excess 
risk of MI (after adjustment for traditional cardiovascular risk factors) is of clinical
importance and highlights that control of traditional risk factors is the 
cornerstone of cardiovascular disease prevention, even in populations with 
psychiatric disorders. Our findings suggest that strict control of cardiovascular 
risk factors among patients with anxiety disorders may reduce the risk of 
coronary or cerebrovascular events to a level equivalent to that for patients 
without anxiety. Our findings for depressive disorders suggest an independent 
effect of depression which persists despite accounting for cardiovascular risk 
factor control. Targeting more intensive management of cardiovascular risk 
factors and evaluating the benefit risk ratio of antidepressant prescribing should 
be prioritized amongst primary care teams.
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Figure 1. Cumulative Hazard Curves for incidence of MI and Stroke in patients with 
Anxiety or Depression
Table 1. Description of study sample
Whole
cohort
Anxiety
cohort
Non-Anxiety cohort p.val for
difference
Depression
cohort
Non-Depression
cohort
p.val for
difference
n (%) n (%) n (%) n (%) n (%)
N 524,952
(100)
22,128 (4.2) 502,824 (95.8) 21,811 (4.1) 503,141 (95.9)
Demographic characteristics at baseline
Mean age (SD) 35.9 (13.9) 42.7 (13.9) 35.6 (13.8) <0.001 43.2 (13.5) 35.6 (13.8) <0.001
Median age (IQR) 32 (25-44) 41 (32-52) 32 (24-43) 42 (33-52) 32 (24-43)
Female 247,528
(47.1)
13,267 (60.0) 234,261 (46.6) <0.001 13,777 (63.2) 233,751 (46.5) <0.001
Male 277,423
(52.8)
8,861 (40.0) 268,562 (53.4) 8034 (36.8) 269,389 (53.5)
White 220,079
(41.9)
13,863 (62.6) 206,216 (41.0) <0.001 13,436 (61.6) 206,643 (41.1) <0.001
South Asian 144,666
(25.6)
3,507 (15.8) 141,159 (28.1) 3,182 (14.6) 141,484 (28.1)
Black 89,186
(17.0)
2,739 (12.4) 86,447 (17.2) 3,155 (14.5) 86,031 (17.1)
Other 32,425 (6.2) 889 (4.0) 31,536 (6.3) 869 (4.0) 31,556 (6.3)
Unknown 38,596 (7.4) 1,130 (5.1) 37,466 (7.5) 1,169 (5.4) 37,427 (7.4)
Mean Townsend score (SD) 5.2 (1.8) 5.4 (1.8) 5.2 (1.8) <0.001 5.5 (1.7) 5.2 (1.8) <0.001
Prevalent cardiovascular risk factors and medication use at baseline
Diabetes mellitus 50,081 (9.5) 2,804 (12.7) 47,277 (9.4) <0.001 3,098 (14.20) 46,983 (9.3) <0.001
Current smoker 145,862
(27.8)
8,378 (37.9) 137,484 (27.3) <0.001 8,897 (40.8) 136,965 (27.2) <0.001
Hypertension 86,946
(16.6)
5,829 (26.3) 81,117 (16.1) <0.001 5,613 (25.7) 81,333 (16.2) <0.001
Hyperlipidemia (≥5 mmol/L) 204,682
(40.0)
13,223 (59.8) 191,459 (38.1) <0.001 13,392 (61.4) 191,290 (38.0) <0.001
Antidepressant use 125,532
(23.9)
15,228 (68.8) 110,304 (21.9) <0.001 16,659 (76.4) 108,873 (21.6) <0.001
Obesity (≥30 kg/m2) 36,195 (6.9) 3,417 (15.4) 32,778 (6.5) <0.001 3,791 (17.4) 32,404 (6.4) <0.001
Anxiety -- -- 5,132 (23.5) 16,996 (3.4) <0.001
Depression 5,132 (23.2) 16,679 (3.3) <0.001 -- --
Incident CVD 2005-2015
Incident MI 3,390 (0.7) 247 (1.1) 3,143 (0.6) <0.001 263 (1.2) 21,327 (0.6) <0.001
Mean age at first MI (SD) 59.5 (13.4) 58.5 (11.2) 61.2 (12.9)
Incident Stroke 987 (0.2) 68 (0.3) 919 (0.2) <0.001 79 (0.4) 908 (0.2) <0.001
Mean age at first Stroke 
(SD)
61.6 (15.3) 63.4 (12.7) 59.2 (13.0)
*Comparisons between patients with/without anxiety and with/without depression were made using t-tests for continuous variables, and from chi-squared test for 
unordered categorical variables
Table 2. Association between anxiety and MI/Stroke (n=524,916) 
Risk of MI Risk of Stroke
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
Anxiety at baseline 1.33*** [1.17,1.52]
1.10 [0.96,1.2
6]
1.08 [0.94,1.2
4]
1.17 [0.91,1.5
1]
1.09 [0.84,1.4
1]
1.06 [0.81,1.3
8]
Age 1.07*** [1.07,1.08]
1.07*** [1.07,1.0
7]
1.07*** [1.07,1.0
7]
1.08*** [1.07,1.0
8]
1.07*** [1.07,1.0
8]
1.07*** [1.07,1.0
8]
Gender
   Female (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 --
   Male 2.87*** [2.66,3.10]
2.82*** [2.61,3.0
5]
2.84*** [2.62,3.0
6]
1.43*** [1.26,1.6
2]
1.43*** [1.26,1.6
3]
1.44*** [1.26,1.6
3]
Ethnic Group
   White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 --
   South Asian 1.86*** [1.71,2.02]
1.86*** [1.71,2.0
3]
1.87*** [1.72,2.0
4]
1.24* [1.04,1.4
8]
1.18 [0.99,1.4
2]
1.19 [1.00,1.4
3]
   Black African/Caribbean 0.52*** [0.46,0.59]
0.51*** [0.45,0.5
7]
0.51*** [0.45,0.5
8]
1.40*** [1.19,1.6
5]
1.29** [1.09,1.5
2]
1.29** [1.09,1.5
3]
   Other ethnic group 0.76** [0.63,0.92]
0.81* [0.68,0.9
8]
0.82* [0.68,0.9
9]
1.09 [0.80,1.4
9]
1.10 [0.80,1.5
0]
1.10 [0.81,1.5
1]
Hypertension 1.17*** [1.07,1.28]
1.17*** [1.07,1.2
8]
1.47*** [1.25,1.7
3]
1.47*** [1.25,1.7
3]
Diabetes Mellitus 1.48*** [1.33,1.63]
1.48*** [1.33,1.6
3]
1.46*** [1.21,1.7
5]
1.46*** [1.21,1.7
5]
Hyperlipidemia 1.12* [1.02,1.22]
1.12* [1.02,1.2
2]
0.89 [0.75,1.0
5]
0.89 [0.75,1.0
5]
Current smoker 2.03*** [1.87,2.20]
2.02*** [1.86,2.1
9]
1.33** [1.12,1.5
9]
1.33** [1.11,1.5
8]
Antidepressant use 1.25*** [1.13,1.39]
1.20*** [1.08,1.3
4]
1.07 [0.87,1.3
0]
1.01 [0.82,1.2
4]
Townsend deprivation 
score
1.06*** [1.04,1.0
9]
1.06*** [1.04,1.0
8]
1.03 [0.99,1.0
7]
1.03 [0.99,1.0
7]
Obesity 1.73*** [1.60,1.8
7]
1.73*** [1.60,1.8
7]
1.45*** [1.25,1.6
8]
1.45*** [1.25,1.6
8]
Depression 1.21** [1.05,1.3
9]
1.29 [1.00,1.6
6]
* Columns display hazard ratio, and 95% confidence interval, *p<0.05 **p<0.01 ***p<0.0001, all models account for clustering by general practice. 
Table 3. Association between depressive disorders and MI/Stroke (n=524,916) 
Risk of MI Risk of Stroke
Model 1 Model 2 Model 3 Model1 Model2 Model 3
Depression at baseline 1.52***
[1.34,1.73] 1.22*** [1.06,1.40] 1.21** [1.05,1.39
]
1.40** [1.11,1.78] 1.29* [1.00,1.6
7]
1.29 [1.00,1.66]
Age 1.07***
[1.07,1.08] 1.07*** [1.07,1.07] 1.07**
*
[1.07,1.07
]
1.08**
*
[1.07,1.08] 1.07*** [1.07,1.0
8]
1.07*** [1.07,1.08]
Gender
   Female (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 --
   Male 2.89***
[2.68,3.12] 2.83*** [2.62,3.06] 2.84**
*
[2.62,3.06
]
1.44**
*
[1.27,1.63] 1.43*** [1.26,1.6
3]
1.44*** [1.26,1.63]
Ethnic Group
   White (ref) 1 -- 1 -- 1 -- 1 -- 1 -- 1 --
   South Asian 1.87***
[1.72,2.03] 1.87*** [1.72,2.04] 1.87**
*
[1.72,2.04
]
1.25* [1.05,1.49] 1.19 [1.00,1.4
3]
1.19 [1.00,1.43]
   Black African/Caribbean 0.52***
[0.46,0.59] 0.51*** [0.45,0.58] 0.51**
*
[0.45,0.58
]
1.41**
*
[1.20,1.66] 1.29** [1.09,1.5
3]
1.29** [1.09,1.53]
   Other ethnic group 0.77** [0.64,0.92] 0.82* [0.68,0.98] 0.82* [0.68,0.99]
1.10 [0.80,1.50] 1.10 [0.81,1.5
1]
1.10 [0.81,1.51]
Hypertension 1.17*** [1.07,1.28] 1.17***
[1.07,1.28
]
1.47*** [1.25,1.7
3]
1.47*** [1.25,1.73]
Diabetes Mellitus 1.47*** [1.33,1.63] 1.48***
[1.33,1.63
]
1.45*** [1.21,1.7
5]
1.46*** [1.21,1.75]
Hyperlipidemia 1.12* [1.02,1.22] 1.12* [1.02,1.22]
0.89 [0.75,1.0
5]
0.89 [0.75,1.05]
Current smoker 2.02*** [1.86,2.19] 2.02***
[1.86,2.19
]
1.33** [1.12,1.5
8]
1.33** [1.11,1.58]
Antidepressant use 1.22*** [1.10,1.35] 1.20***
[1.08,1.34
]
1.02 [0.83,1.2
5]
1.01 [0.82,1.24]
Townsend deprivation 
score
1.06*** [1.04,1.08] 1.06**
*
[1.04,1.08
]
1.03 [0.99,1.0
7]
1.03 [0.99,1.07]
Obesity 1.73*** [1.60,1.87] 1.73**
*
[1.60,1.87
]
1.45*** [1.25,1.6
8]
1.45*** [1.25,1.68]
Anxiety 1.08 [0.94,1.24
]
1.06 [0.81,1.38]
* Columns display hazard ratio, and 95% confidence interval, *p<0.05 **p<0.01 ***p<0.0001, all models account for clustering by general practice. 
Table 4. Age at first presentation of MI and Stroke 
Difference in age at presentation (years)
MI Coefficient CI95% p.va;
Anxiety -3.6 -5.0 – -2.1 <0.001
Depression -1.0 -2.5 – 0.5 0.203
Stroke
Anxiety 0.5 -2.7 – 3.7 0.736
Depression -4.1 -7.1 – -1.1 0.008
**All models adjusted for gender and ethnic group, and clustering by general practice
Highlights
• The study finds strong evidence for an independent association between 
depression and cardiovascular events, and weaker evidence for an association 
with anxiety.
• Mean age at first MI is lower in those with anxiety compared to those without 
anxiety, while mean age at first stroke is lower in those with depression 
compared to those without depression. 
• The study shows an independent effect of antidepressant prescribing on risk of 
MI, but not stroke. 
• The findings highlight that that control of traditional risk factors is the 
cornerstone of cardiovascular disease prevention in populations with psychiatric 
conditions.
• Targeting intensive management of classical cardiovascular risk factors and 
evaluating the benefit risk ratio of antidepressant prescribing should be 
prioritized amongst primary care teams.
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CONSULTATION:Depression 1 AGORAPHOBIA 1
Chronic depression 1,522 ANXIETY REACTION 1
DEPRESSION 41 ANXIETY STATE 1
Depressed Mood 1 Acrophobia 2
Depression 5,085 Acute Anxiety State 16
Depression NOS 1,163 Agoraphobia 90
Depression NOS tearful and low mood pre 1 Agoraphobia - no panic attacks 1
Depressive disorder 6 Agoraphobia - no panic attacks (GMS) 1
Depressive disorder NEC 7,132 Agoraphobia with panic attacks 290
Mild depression 31 Agoraphobia without mention of panic att 24
Mild depression (GMS) 2 Animal phobia 39
Moderate depression 54 Anxiety & Depression 4
Moderate major depression 1 Anxiety State 3
Postviral depression 8 Anxiety Symptoms 197
Premenstrual dysphoric disorder 8 Anxiety Symptoms Related To Bomb 12
Query Depressive disorder NEC 1 Anxiety disorder 4
Query [X]Moderate depressive episode 1 Anxiety state 2,676
Recurrent major depressive episodes, sev 186 Anxiety state NOS 2,321
Severe depression 40 Anxiety state unspecified 647
Single major depressive episode, severe, 2 Anxiety states 14,274
[X] Reactive depression NOS 1,288 Anxiety with depression 18,338
[X]Antenatal depression 1 Cancer phobia 68
[X]Atypical depression 8 Chronic Anxiety State 9
[X]Depression NOS 17,170 Chronic anxiety 799
[X]Depressive disorder NOS 111 Claustrophobia 401
[X]Depressive episode 1,910 Dental phobia 69
[X]Depressive episode, unspecf 15 Fear of crowds 2
[X]Depressive episode, unspecf (GMS) 184 Fear of death 9
[X]Depressive episode, unspecified 1,226 Fear of flying 1,241
[X]Endogen depress no psychot 4 Fear of pregnancy 36
[X]Endogen depress+psychot 1 Flying Fear /Ox 1
[X]Endogenous depression with psychotic 21 Generalised anxiety disorder 812
[X]Endogenous depression without psychot 3 Mixed anxiety and depressive disorder 30
[X]Major depression, mild 3 Mixed anxiety and depressive disorder (G 4
[X]Major depression, moderately severe 36 Needle Phobia 1
[X]Major depression, recurrent without p 5 Other Phobias 12
[X]Major depression, severe with psychot 47 Other phobias 58
[X]Major depression, severe without psyc 15 PANIC ATTACK (S) 2
[X]Manic-dep,depress+psychotic 1 PANIC ATTACK(S) 7
[X]Manic-depress psychosis,depressd,no p 1 PHOBIA 1
[X]Manic-depress psychosis,depressed typ 2 Panic Attacks 27
[X]Mild depression 409 Panic Disorder 2
[X]Mild depressive episode 1,736 Panic attack 6,058
[X]Moderate depressive episode 4,195 Panic disorder 1,219
[X]Moderate depressve episode (GMS) 18 Panic disorder without agoraphobia 2
[X]Monopolar depression NOS 1 Phobia unspecified 170
[X]Other depressive episodes 34 Phobic Anxiety 33
[X]Other recurrent depressive disorders 7 Phobic State 1
[X]Prolonged single episode of reactive 6 Phobic anxiety 303
[X]Rec psychogen dep psychosis 1 Phobic disorder NOS 24
[X]Recur epis/psychogen depres 1 Phobic disorders 41
[X]Recur epis/react depression 1 Phobic state 3
[X]Recur,major dep+psychotic 1 Query Generalised anxiety disorder 1
[X]Recurr dep now sever+psych 1 Query Panic attack 3
[X]Recurr dep now sever+psych (GMS) 2 Query Panic disorder 1
[X]Recurr depress disorder cur epi sever 6 Recurrent anxiety 331
[X]Recurr major depr ep, severe with psy 45 School Phobia 1
[X]Recurr severe episodes/major depressi 4 Social phobia (GMS) 1
[X]Recurrent depress disorder cur epi se 10 Social phobia, fear of public speaking 29
[X]Recurrent depressive disord (GMS) 4 Social phobia-eating in public (GMS) 1
[X]Recurrent depressive disorder 504 Social phobic disorders 62
[X]Recurrent depressive disorder, curren 10 Stress - acute reaction 2
[X]Recurrent depressive disorder, curren 19 Test request: Anxiety with depression 1
[X]Recurrent depressive disorder, curren 10 Weight fixation 3
[X]Recurrent depressive disorder, unspec 26 [X]Agoraphob no hist/panic dis 21
[X]Recurrent episodes of depressive reac 1 [X]Agoraphobia 273
[X]Recurrent episodes of psychogenic dep 3 [X]Agrophob no hist/panic dis 3
[X]Recurrent episodes of reactive depres 4 [X]Animal phobias 5
[X]Recurrent psychotic depress 30 [X]Anxiety NOS 2,742
[X]Recurrent severe episodes of psychoti 4 [X]Anxiety disord unspecified (GMS) 1
[X]Recurrent severe episodes/reactive de 1 [X]Anxiety disorder, unspecified 202
[X]SAD - Seasonal affective disorder 21 [X]Anxiety hysteria 8
[X]SAD-Seasonl affectiv disord 15 [X]Anxiety neurosis 236
[X]Seasonal depressive disorder 3 [X]Anxiety reaction 275
[X]Seasonal depressive disordr 4 [X]Anxiety state 514
[X]Severe depressiv no psychot (GMS) 5 [X]Claustrophobia 15
[X]Severe depressive + psychot 1 [X]Generalized anxiety disord 1
[X]Severe depressive + psychot (GMS) 7 [X]Generalized anxiety disord (GMS) 11
[X]Severe depressive episode with psycho 215 [X]Generalized anxiety disorder 151
[X]Severe depressive episode without psy 1,215 [X]Mild anxiety depression 144
[X]Sgl epi,maj depres+psyc sym 3 [X]Mixed anxiety and depressive disorder 486
[X]Single epis/depress react 1 [X]Mixed anxiety/depressve dis (GMS) 1
[X]Single epis/psychog depress 1 [X]Needle phobia 210
[X]Single episode agitated depressn w'ou 1 [X]Other anxiety disorders 58
[X]Single episode major depression w'out 7 [X]Other mixed anxiety disord (GMS) 1
[X]Single episode of depressive reaction 1 [X]Other mixed anxiety disorders 3
[X]Single episode of major depression an 2 [X]Other phobic anxiety disord 1
[X]Single episode of masked depression N 1 [X]Other phobic anxiety disorders 3
[X]Single episode of psychogenic depress 1 [X]Other specif anxiety disord (GMS) 1
[X]Single episode of psychogenic depress 1 [X]Other specified anxiety disorders 6
[X]Single episode of psychotic depressio 10 [X]Panic attack 98
[X]Single episode of reactive depression 15 [X]Panic disorder [episodic paroxysmal a 57
[X]Single episode of reactive depressive 2 [X]Panic disorder with agoraphobia 19
[X]Single major depr ep, severe with psy 1 [X]Panic disorder with agrophobia 1
[X]Sngl episd/reactive depresn 3 [X]Panic disorder+agoraphobia 54
[X]Sngl episod/psychot depress 1 [X]Panic disorder+agrophobia 2
depression 3 [X]Panic episodic paroxysm anx (GMS) 5
depression, MNW, NFD 1 [X]Panic state 38
  [X]Phobia NOS 49
  [X]Phobic anxiety disorder, unspecified 7
  [X]Phobic anxiety disorders 32
  [X]Phobic anxiety disordr unsp (GMS) 4
  [X]Phobic state NOS 6
  [X]Simple phobia 16
  [X]Social neurosis 3
  [X]Social phobias 118
  [X]Specific (isolated) phobia 2
  [X]Specific (isolated) phobia (GMS) 1
  [X]Specific (isolated) phobias 75
  anxiety /ox 2
  anxiety autonomic situational /ox 19
  flying fear /ox 1
  phobia against flying recent going on 1
  pregnancy fear /ox 1
